Icon

Integrated delivery of CRO services

Friday, September 1, 2017

Unified delivery of a broad range of services by a CRO within a single clinical trial can be difficult to do as each role within a CRO—be it a Clinical, Data or Laboratory Project Manager, is primarily focused on delivery of their own aspects of the trial.

[Read More]

WCG’s MedAvante-ProPhase expands executives

Tuesday, August 15, 2017

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, announced that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvanteProPhase, the Group’s electronic clinical outcomes assessment (eCOA) arm. Herne and Cioffi are tasked with expanding MedAvante-ProPhase’s already formidable portfolio of services and technologies, which improve the quality of clinical trial data collection and analysis in the fields of CNS and mental health.

[Read More]

ICON acquires Mapi Group

Monday, July 31, 2017

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has acquired the Mapi Group, a Patient-Centered Health Outcomes Research and Commercialization company.

[Read More]

Ergomed appoints Dr Dan Weng as CEO

Friday, June 23, 2017

Ergomed, a company dedicated to the provision of specialized services to the pharmaceutical industry and the development of new drugs, announced the strengthening of its executive team with the appointment of Dr. Dan Weng as its new chief executive officer and a board director of Ergomed. Dr. Weng joins Ergomed with effect from 1 July 2017 from EPS Holdings (EPSHD), a global CRO listed on the Tokyo Stock Exchange.

[Read More]

Icon, Regeneron win Best Partnership in Clinical Research award from PharmaTimes

Thursday, May 25, 2017

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and Regeneron Pharmaceuticals, a science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions, have won the Partnership in Clinical Research award at the 2017 PharmaTimes International Clinical Researcher of the Year Awards, which took place in London on 18th May. The companies were represented by Agnieszka Szpineta of Icon and Jacquie Kuritzky of Regeneron.

[Read More]